|
GPSM2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.524200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.065900E-02 |
| Normal-vs-Stage2 |
4.06440000000341E-05 |
| Normal-vs-Stage3 |
4.818800E-01 |
| Normal-vs-Stage4 |
7.277200E-01 |
| Stage1-vs-Stage2 |
2.879100E-03 |
| Stage1-vs-Stage3 |
1.656230E-01 |
| Stage1-vs-Stage4 |
1.809970E-01 |
| Stage2-vs-Stage3 |
2.906100E-02 |
| Stage2-vs-Stage4 |
1.399510E-02 |
| Stage3-vs-Stage4 |
6.916400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.364400E-01 |
| Normal-vs-AfricanAmerican |
8.143800E-01 |
| Normal-vs-Asian |
1.000080E-02 |
| Caucasian-vs-AfricanAmerican |
6.557200E-01 |
| Caucasian-vs-Asian |
1.329430E-01 |
| AfricanAmerican-vs-Asian |
3.177800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.797400E-01 |
| Normal-vs-Female |
3.380500E-02 |
| Male-vs-Female |
1.156630E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.545600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.274600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.636200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.544800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.396400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.762020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.852180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.890410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.246950E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.435630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.661800E-01 |
| Classical-VS-Follicular |
4.738800E-01 |
| Classical-VS-Other |
9.872600E-01 |
| Classical-VS-Normal |
1.822810E-01 |
| Tall-VS-Follicular |
6.883200E-01 |
| Tall-VS-Other |
8.349200E-01 |
| Tall-VS-Normal |
7.909800E-01 |
| Follicular-VS-Other |
5.939000E-01 |
| Follicular-VS-Normal |
7.780600E-01 |
| Other-VS-Normal |
5.650400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.503800E-01 |
| Normal-vs-N1 |
1.627230E-01 |
| N0-vs-N1 |
6.164000E-01 |
|
|
